Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Citizen Meds vs LaSara Medical Group

Citizen Meds
Graded #254

Higher grade

vs+9.200000000000003
LaSara Medical Group
Graded #456

Lower grade

The verdict

Citizen Meds takes it — 63.7/100 to 54.5/100.

Citizen Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Citizen Meds is a GLP-1/weight-loss injection provider offering semaglutide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCitizen Meds +37
70
33
Dose & formulationLaSara Medical Group +10
54
64
Clinical oversightCitizen Meds +10
79
69
Labs & monitoringLaSara Medical Group +1
52
53
FulfillmentLaSara Medical Group +4
62
66
Contract termsCitizen Meds +8
55
47
Citizen Meds · left barLaSara Medical Group · right bar

The numbers

MetricCitizen MedsLaSara Medical Group
WeighScore63.7/10054.5/100
GradeCC
Scorecard rank#254#456
Semaglutide$125/mo (0.25 mg dose, compounded)$289/mo (compounded)
Tirzepatide$185/mo (2.5 mg dose, first-month rate, compounded)$399/mo (bundle, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Citizen Meds

Graded #254 · C

Strengths

  • Semaglutide confirmed from product listings
  • New-patient discount available (code NEWPATIENT10)

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • State availability not disclosed
  • About page returns a 404
  • Limited overall transparency
LaSara Medical Group

Graded #456 · C

Strengths

  • Multi-modality clinic — compounded GLP-1s alongside TRT, peptides, B12, NAD+, sermorelin, and enclomiphene
  • National telehealth plus an in-person option in Southern California — uncommon hybrid model
  • Free initial consultation
  • Active promotional pricing (30% off sitewide at the time of review)
  • GLP-1 pricing now published on product pages: compounded semaglutide from $233/mo, tirzepatide from $325/mo on annual bundles

Where it loses points

  • Legal entity name and state of incorporation not disclosed
  • Compounding pharmacy partner not named
  • LegitScript certification status not confirmed
  • Per-state availability not listed despite the national-telehealth claim
  • Lab work and ongoing monitoring inclusion not clearly disclosed for the multi-modality menu

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard